Prosecution Insights
Last updated: April 19, 2026
Application No. 18/026,113

THERMOPLASTIC RESIN COMPOSITION, METHOD OF PREPARING THE SAME, AND MOLDED ARTICLE MANUFACTURED USING THE SAME

Non-Final OA §112§DP
Filed
Mar 13, 2023
Examiner
LENIHAN, JEFFREY S
Art Unit
1765
Tech Center
1700 — Chemical & Materials Engineering
Assignee
LG Chem, Ltd.
OA Round
1 (Non-Final)
73%
Grant Probability
Favorable
1-2
OA Rounds
3y 1m
To Grant
90%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allow Rate
665 granted / 910 resolved
+8.1% vs TC avg
Strong +17% interview lift
Without
With
+16.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
47 currently pending
Career history
957
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
43.2%
+3.2% vs TC avg
§102
15.1%
-24.9% vs TC avg
§112
28.2%
-11.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 910 resolved cases

Office Action

§112 §DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Double Patenting Claim 1 and 9-15 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 2 and 9-15 of copending Application No. 18/565,896 (reference application). Although the claims at issue are not identical, they are not patentably distinct from each other. Copending claim 2 recites a thermoplastic composition (for claim 1) comprising a graft copolymer and a non-graft copolymer which is an alkyl (meth)acrylate/alkyl-substituted styrene/vinyl cyanide copolymer, corresponding to claimed non-graft copolymer (B) (for claim 1). The graft copolymer of the copending claims comprises a seed which is 35 to 58 wt% alkyl acrylate and 42 to 65 wt% aromatic vinyl compound, corresponding to the claimed seed (for claim 1); a rubber core which is 78 to 91 wt% alkyl acrylate and 9 to 22 wt% vinyl aromatic monomer, corresponding to the claimed rubber core (for claim 1); and a shell which is 65 to 82 wt% vinyl aromatic compound, 12 to 30 wt% vinyl cyanide, and 3 to 15 wt% alkyl acrylate, corresponding to the claimed shell (for claim 1). Said graft copolymer satisfies the equations 180 ≤ 2*r2 ≤300, overlapping claimed equation 1 (for claim 1) and 25≤ r2-r1 ≤ 45,corresponding to claimed equation 2 (for claim 1), wherein r1 and r2 have the same definitions as in the instant claim. Regarding claims 9-12, 15: Copending claims 9, 10, 11, 12 and 15 depend from claim 2 and recite limitations that overlap the scope of the instant claims 9, 10, 11, 12, and 15, respectively. Regarding claim 13: Copending claim 13 recites a method of making a thermoplastic composition by kneading and extruding at 180 to 300 °C and 80 to 400 rpm a graft copolymer and a non-graft copolymer which are defined in the same manner as in copending claim 2, discussed above. Note that the ranges for the amounts of each monomer in the seed, core, and shell of the graft copolymer overlap the ranges recited in the instant claims. Regarding claims 14: Copending claim 14 depends from claim 13 and states that the process further includes an alkyl acrylate/vinyl aromatic/vinyl cyanide graft copolymer having an average diameter of 50 to 150 nm. The copending claims do not specifically recite a graft copolymer in which the seed, core, and shell comprise the disclosed monomers within the claimed ranges. It has been held that in the case where the claimed ranges overlap or lie inside ranges disclosed in the prior art, a prima facie case of obviousness exists; see In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). The normal desire of scientists or artisans to improve upon what is already generally known provides the motivation to determine where in a disclosed set of percentage ranges is the optimum combination of percentages; see In re Peterson, 315 F.3d at 1330, 65 USPQ2d at 1382 (" (MPEP § 2144.05). Note that the ranges for the amounts of monomers in the copending claim overlap the ranges recited in the instant claims. Barring a showing of evidence demonstrating unexpected results, it therefore would have been obvious to prepare the claimed composition in view of the copending claims (for claim 1). This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-15 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding claims 1 and 13: Claims 1 and 13 each recite the limitation of a non-graft copolymer (B) which comprises an alkyl-substituted styrene-based compound; this limitation with regards to the phrase “alkyl-substituted styrene-based compound”. Styrene has the structure shown below. PNG media_image1.png 173 176 media_image1.png Greyscale It is unclear whether the phrase “alkyl-substituted styrene-based compound” is intended to include only compound(s) having a structure wherein the styrene structure shown above is substituted with one or more alkyl groups, or if the inclusion of the term “-based” is intended to read on compounds that can be obtained as derivatives of alkyl-substituted styrenes-for instance, compounds wherein the ring is hydrogenated or the alkyl group has been functionalized with a heteroatom-containing moiety. Additionally, the r1 average radius and r2 average radius in claims 1 and 13 are indefinite as it is unclear whether these variables refer to the radius from the center of the graft copolymer to the exterior point of the polymer seed and core, respectively, or to any point within the seed and core. Regarding claim 5: The phrase “alkyl-substituted styrene-based compound” is indefinite as discussed above with respect to claim 1. Regarding claims 2-12, 14, 15: The instant claims depend from either claim 1 or claim 13 and do not correct the deficiencies discussed above. The claims are therefore indefinite per the same rationale as claims 1 and 13. Allowable Subject Matter Claims 2-4, 6-12, 14, and 15 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: The closest prior art of record is Kim et al, US2014/0235749. Kim discloses an acrylonitrile-acrylate-styrene graft copolymer having a seed/core/shell structure, wherein the prior art graft copolymer satisfies the equations 1.50 ≤ 2*r2 ≤ 350 and 20 ≤ r2-r1 ≤ 50, wherein r1 is a radius from the center of the graft copolymer to the seed and r2 is a radius from the graft copolymer center to the core (abstract; ¶0039). Kim closest example (¶0073: Example 11) discloses a styrene/acrylonitrile/methyl methacrylate seed wherein the amount of styrene is three times greater than the combined amounts of acrylonitrile and methyl methacrylate in contrast to the claimed invention, which requires that the seed comprise 51 to 77 wt% alkyl (meth)acrylate. Further note that Kim does not disclose any broad ranges for the amounts of monomer(s) in each stage of the prior art graft copolymer. Kim therefore does not suggest the production of a graft copolymer wherein each of the seed, core, and shell layers comprises the required monomers in the amounts recited in claims 1 and 13. Additionally, no reference has been found that would provide a motivation to one of ordinary skill in the art to modify the prior art graft copolymer to comprise a seed containing 51 to 77 wt% first alkyl (meth)acrylate and 23 to 49 wt% first aromatic vinyl compound, a rubber core containing 78 to 90 wt% first alkyl acrylate and 10 to 22 wt$ second aromatic vinyl compound; and a shell containing 65 to 80 wt% third vinyl aromatic compound, 14 to 25 wt% first vinyl cyanide compound, and 3 to 15 wt% second alkyl acrylate while also meeting Kim’s requirements that the difference between the refractive index of the seed and/or shell and that of the matrix polymer to which the graft copolymer is added is less than 0.035 and the difference in refractive index of the core to that of the matrix is higher than 0.056 (¶0044). Kim therefore fails to teach or suggest the invention as defined in the instant claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JEFFREY S LENIHAN whose telephone number is (571)270-5452. The examiner can normally be reached Mon.-Fri. 5:30-2:00PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi Riviere Kelley can be reached at 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JEFFREY S LENIHAN/Primary Examiner, Art Unit 1765
Read full office action

Prosecution Timeline

Mar 13, 2023
Application Filed
Mar 07, 2026
Non-Final Rejection — §112, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600810
PROCESS FOR PREPARING OLEFIN-ACRYLATE BLOCK COPOLYMERS
2y 5m to grant Granted Apr 14, 2026
Patent 12590223
METHOD FOR PREPARING METALLOPOLYMER-BASED COATING SOLUTION
2y 5m to grant Granted Mar 31, 2026
Patent 12577425
ANTIBACTERIAL POLYMER COMPOSITION COMPRISING POLYMER COMPOUND OBTAINED BY GRAFT POLYMERIZING CATIONIC MONOMER AND FLUORINE-BASED ACRYLIC MONOMER TO FLUORINE-BASED COPOLYMER
2y 5m to grant Granted Mar 17, 2026
Patent 12577342
Acrylic Emulsions Modified with Functional (Meth)acrylates to Enable Crosslinking
2y 5m to grant Granted Mar 17, 2026
Patent 12540242
EPOXY RESIN COMPOSITION, CURED PRODUCT, AND ELECTRICAL OR ELECTRONIC COMPONENT
2y 5m to grant Granted Feb 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
73%
Grant Probability
90%
With Interview (+16.8%)
3y 1m
Median Time to Grant
Low
PTA Risk
Based on 910 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month